ENVERIC BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Enveric Biosciences, Inc. - ENVB
By:
Kahn Swick & Foti, LLC via
Business Wire
June 01, 2021 at 18:57 PM EDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of MagicMed Industries Inc. to Enveric Biosciences, Inc. (“the Company”) (NasdaqCM: ENVB). Under the terms of the proposed transaction, current Enveric shareholders will own only approximately 63.4% of the combined company's common stock. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders. If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-envb/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20210601006093/en/ Contacts
Kahn Swick & Foti, LLC
More NewsView More
Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift ↗
December 05, 2025
Via MarketBeat
Tickers
RKLB
Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish ↗
December 05, 2025
Snowflake Stock: The Dip That Smart Investors Are Buying Right Now ↗
December 05, 2025
Via MarketBeat
Via MarketBeat
Tickers
KRKNF
Via MarketBeat
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|